Trevor Martin

Trevor Martin is the co-founder and CEO of Mammoth Biosciences, a biotech company based in San Francisco that focuses on advancing CRISPR technology for diagnostics and therapeutics. His work aims to democratize access to CRISPR-based solutions across various fields, including healthcare, agriculture, and environmental monitoring.145

Education and Early Career

• Princeton University: Martin earned a Bachelor of Arts in Molecular Biology, graduating with honors in 2011. He was awarded the Molecular Biology Senior Thesis Prize for his work.23
• Stanford University: He completed his PhD in Genetics and Statistics in 2016, during which he was a National Science Foundation Graduate Research Fellow.23

Professional Achievements

• Mammoth Biosciences: Since co-founding the company in 2017, Martin has been instrumental in developing CRISPR-enabled molecular diagnostics aimed at making health information accessible and actionable for individuals globally.14
• Recognition: He has received several accolades, including being named to Fortune's "40 Under 40" and Forbes' "30 Under 30" lists in 2019 for his contributions to healthcare innovation.23

Research Focus

Martin's research interests include novel classes of CRISPR systems, particularly the Cas14 proteins, which have potential applications in gene editing and diagnostics. His vision is to create affordable and efficient tools that can transform how we understand and manipulate biological systems.15